SCIREQ - an emka TECHNOLOGIES Company

SCIREQ strives to make a strong impact on global pulmonary health by empowering scientists to better understand and eradicate lung diseases. The global burden of respiratory diseases is primarily driven by asthma, chronic obstructive pulmonary disease and acute respiratory infections. However, a plethora of rare lung diseases such a Cystic Fibrosis, Idiopathic Pulmonary Fibrosis and many other diseases severely compromise the quality of life of millions of patients and their loved ones.